Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BriaCell Therapeutics Corp. BCTXZ

Full chart Compare
Set alert

Price alert · BCTXZ

All alert types
0.11 USD 0.00 (+3.99%)

At closeNov 4, 2026, 4:00 PM EST

0.22 +0.11 +91.97%

After hours · Nov 4, 4:00 PM ET

0.1146 Day range 0.1146
0.1146 52-week range 0.1146
YTD
0.00%
1 year
0.00%

Financial health

Altman Z-Score

-18.85 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -0.0×
FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -0.0×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.0×FY 2026: -0.0×
FY 2017 5y median -0.0× FY 2026
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -0.0×FY 2024: -0.1×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/FCF -0.0×
FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -0.0×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.0×FY 2026: -0.0×
FY 2017 5y median -0.0× FY 2026
EV/EBITDA 0.0×
FY 2017: 0.4×FY 2018: -0.1×FY 2019: -0.0×FY 2020: -0.1×FY 2021: 8.1×FY 2022: 1.5×FY 2023: 0.9×FY 2024: 0.1×FY 2025: 0.4×FY 2026: 0.0×
FY 2017 5y median 0.4× FY 2026
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -6388.4%
FY 2017: -51679.4%FY 2018: -102007.8%FY 2019: -76270.5%FY 2020: -18595.4%FY 2021: -19635.5%FY 2022: -9226.2%FY 2023: -17406.8%FY 2024: -17106.4%FY 2025: -22471.9%FY 2026: -6388.4%
FY 2017 5y median -17106.4% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -224.3%
FY 2017: -344.4%FY 2018: -439.6%FY 2019: 684.2%FY 2020: 111.9%FY 2021: -49.9%FY 2022: -259.8%FY 2023: 537.5%FY 2024: 201.1%FY 2025: -148.4%FY 2026: -224.3%
FY 2017 5y median -148.4% FY 2026
ROIC 0.0%
FY 2017: -344.2%FY 2018: -184.9%FY 2019: 1383.0%FY 2020: 123.4%FY 2021: -12.1%FY 2022: -36.7%FY 2023: -91.8%FY 2024: 2097.7%FY 2025: -155.3%FY 2026: 0.0%
FY 2017 5y median -36.7% FY 2026
ROA -148.0%
FY 2017: -157.9%FY 2018: -181.8%FY 2019: -1059.9%FY 2020: -770.5%FY 2021: -23.8%FY 2022: -63.0%FY 2023: -74.7%FY 2024: -81.6%FY 2025: -122.6%FY 2026: -148.0%
FY 2017 5y median -81.6% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income 100.0%
FY 2017: -47.8%FY 2018: -54.6%FY 2019: -25.0%FY 2020: 22.2%FY 2021: -44.2%FY 2022: -119.2%FY 2023: -52.2%FY 2024: -43.2%FY 2025: 17.4%FY 2026: 100.0%
FY 2017 FY 2026
EPS (diluted) 88.9%
FY 2017: 0.0%FY 2018: -33.3%FY 2019: 16.8%FY 2020: 30.7%FY 2021: 55.0%FY 2022: 44.5%FY 2023: 24.9%FY 2024: 77.6%FY 2025: -44.1%FY 2026: 88.9%
FY 2017 FY 2026
Free Cash Flow -0.9%
FY 2017: -22.1%FY 2018: -159.1%FY 2019: -2.7%FY 2020: 69.5%FY 2021: -398.7%FY 2022: -61.1%FY 2023: -90.2%FY 2024: -3.5%FY 2025: -16.0%FY 2026: -0.9%
FY 2017 FY 2026

Financial Health

Current Ratio 2.8×
FY 2017: 1.8×FY 2018: 1.4×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 104×FY 2022: 45.0×FY 2023: 15.0×FY 2024: 0.5×FY 2025: 5.0×FY 2026: 2.8×
FY 2017 5y median 5.0× FY 2026
Quick Ratio 2.8×
FY 2017: 1.8×FY 2018: 1.4×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 104×FY 2022: 45.0×FY 2023: 15.0×FY 2024: 0.5×FY 2025: 5.0×FY 2026: 2.8×
FY 2017 5y median 5.0× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 1.2×FY 2019: -0.5×FY 2020: -0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.0×
FY 2017: 0.4×FY 2018: -0.1×FY 2019: -0.0×FY 2020: -0.1×FY 2021: 8.1×FY 2022: 1.5×FY 2023: 0.9×FY 2024: 0.2×FY 2025: 0.4×FY 2026: 0.0×
FY 2017 5y median 0.4× FY 2026
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: -244×FY 2019: -199×FY 2020: -134×FY 2021: -87.1×FY 2022: -15617×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -736×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-07-31